This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.
This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.
AmerisourceBergen has introduced Clinical Trial Navigator, suite of solutions that offers assistant with biopharmaceutical clinical trial recruitment specifically within community-based specialty practices. The tech is designed to partner cancer care providers and patients with trial opportunities.
“Historically, it has been difficult for biopharmaceutical companies to have a consolidated and holistic view of independent specialty practices and their patient populations, and, as a result, clinical trial enrollment and logistics in these care settings have been complex and difficult to execute,” said Jennifer Sherak, senior vice president and president of specialty physician services. “With Clinical Trial Navigator, we want to break down these barriers for biopharma companies, bring more clinical trials into communities nationwide, help broaden the patient populations being considered for trials, and ultimately advance accrual time and bring therapies to market faster.”
Life-sciences commercialization specialist Eversana is joining forces with Limitless Minds to launch an integrated learning and performance solution for life-sciences professionals. Limitless Minds is a business and wellness coaching firm founded by US football star Russell Wilson.
“We’re thrilled to partner with Eversana and help add the Limitless Minds curriculum and programs to the company’s growing and robust training and development programs,” said Wilson. “Together we can help employees realize their greatest potential, helping drive innovation at companies and helping more patients access therapies worldwide.”
Digital therapeutics company Sidekick Health has announced a partnership with Pfizer to launch an an integrated digital therapeutics (DTx) solution for improving the outcomes of patients with atopic dermatitis. The companies will be rolling out the DTx offering first in the UK, then followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022.
Tryggvi Thorgeirsson, CEO and co-founder of Sidekick, said, “At Sidekick, it’s always been our ambition to help as many people as possible to make long-lasting improvements to their disease management, with the aim of improving people’s health outcomes and quality of life. Our work with Pfizer escalates our mission to bring digital therapeutics into the homes of people around the world.”
Thermo Fisher Scientific has added Direct Mass Technology mode to augment its Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities. The feature enables users to utilize direct mass determination of hundreds to thousands of individual ions in a single spectrum.
“Direct Mass Technology mode combines charge detection with our trusted high-resolution accurate mass Orbitrap measurements to achieve results unattainable by current ensemble measurement techniques,” said Iain Mylchreest, vice president of research and development for analytical instruments with Thermo Fisher Scientific. “By dissolving the complexity barriers inherent to other approaches, we’re enabling a wealth of investigations that were once firmly out of reach — from resolving heavily modified proteoforms to revealing small changes in large antibody-drug conjugate complexes, to name but a few.”
Supply chain technology solutions provider ParkourSC has expanded its platform by offering “digital twins” designed for real-time supply chain operations across an expanded enterprise. It is designed to help overcome disruptions and increase visibility.
ParkourSC CEO Mahesh Veerina said, “Our real-time supply chain operations platform enables companies to digitize their supply chains, embed intelligence, automate workflows, and optimize operations to increase revenue, reduce operating costs and improve profits. With ParkourSC, organizations can move beyond visibility in their supply chains to drive innovation, competitive advantage, and growth through new products and services.”
The Gerresheimer traceability concept is designed to ensure complete transparency throughout the value chain and safeguard patient safety. The company applies unique codes to its primary packaging and medical devices, enabling all stakeholders downstream to link, analyze, and share any data with the individual product unit.
"Our vision includes transparency and traceability across the entire supply chain, from primary packaging to secondary packaging to filling and serialization of medicines to final use at the point of contact," said Lea Amstad, digital strategy lead with Gerresheimer.
R&D cloud technology company Benchling has launched its AlphaFold beta feature. The AI platform, used to predict the 3D structure of a protein, is intended to help users overcome some of the challenges associated with implementation, computing power, and resourcing.
“Our team gets excited about two things: science and bringing software to science,” said Ashu Singhal, president and co-founder of Benchling. “By making AlphaFold available to the biotech industry at the click of a button, scientists will be able to seamlessly experiment with this exciting advancement and find new ways to leverage AlphaFold output in their research.”
Medical supplies company Reliable Healthcare Solutions has announced plans to upgrade its logistics operations and maintain stricter control over its processes using Easy WMS warehouse management software from Interlake Mecalux in its Jacksonville, Florida warehouse.
“Digitization will enable us to gain operational efficiency for both labor and physical space and monitor operations more accurately,” said Gary Teleky, Operations Manager at Reliable Healthcare Solutions. Additionally, the software will send operators detailed instructions on how to perform each operation, from goods receipt to order fulfillment and dispatch.
